Efficacy and Safety of Left Bundle Area Pacing Vs Right Ventricular Apical Pacing in Patients with Atrioventricular Block

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorAssiut University

About this trial

This study will address whether LBBaP is superior to RVAP in terms of safety and efficacy

Eligibility criteria

Qualifiers

Patients with AVB who meet indications for pacemaker

Implantation with an estimated percentage of ventricular pacing ≥50%

Ability to provide informed consent

Disqualifiers

Failure to cooperate with follow-up.

Persistent atrial fibrillation.

Patients with heart failure (LVEF) ≤35%,

Estimated glomerular filtration rate less than 30 ml/min.

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

42 Participants
are grouped into 2 trial groups

Sponsors and collaborators